Beca, Jaclyn, et al. “Cost-Effectiveness of Docetaxel in High-Volume Hormone-Sensitive Metastatic Prostate Cancer”. Canadian Urological Association Journal, vol. 13, no. 12, Apr. 2019, pp. 396-03, doi:10.5489/cuaj.5889.